Home/Recalls/CANADA-22818
Health CanadaGeneral Alert

Bisphosphonate osteoporosis drugs (Aclasta, Actonel, Didrocal, Fosamax, Fosavanc...

Published: December 19, 2011Recall ID: 22818Category: generalCountry: Canada

Product Description & Identification

Bisphosphonate osteoporosis drugs (Aclasta, Actonel, Didrocal, Fosamax, Fosavance): Small but increased risk of unusual thigh bone fractures

Additional Source Details

FieldValue
N I D22818
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/bisphosphonate-osteoporosis-drugs-aclasta-actonel-didrocal-fosamax-fosavance-small
Title Bisphosphonate osteoporosis drugs (Aclasta, Actonel, Didrocal, Fosamax, Fosavance): Small but increased risk of unusual thigh bone fractures
Archived1
CategoryDrugs
Last updated2011-12-19
OrganizationCommunications and Public Affairs Branch

Overview

  • Recalling FirmCommunications and Public Affairs Branch
Official Agency Alert